Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
No open-market purchases or sales by Passage BIO, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Passage BIO, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 110 | 4 | 87 | −19 |
| Shares | 43.0M | 179.0K | 42.2M | −608.2K (−1.4%) |
| Value | $133.2M | $555.0K | $99.6M | −$33.1M (−24.9%) |
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Passage BIO, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rubric Capital Management LP | 822,105 | $1.94M | 0.10% |
| Newtyn Management, LLC | 620,000 | $1.46M | 0.28% |
| Oasis Management Co Ltd. | 240,000 | $566.0K | 0.10% |
| Ergoteles LLC | 168,341 | $397.0K | 0.01% |
| New York Life Investment Management LLC | 150,432 | $355.0K | 0.00% |
| RBF Capital, LLC | 114,207 | $270.0K | 0.02% |
| Alyeska Investment Group, L.P. | 100,000 | $236.0K | 0.00% |
| Cornercap Investment Counsel Inc | 67,098 | $158.0K | 0.03% |
| Susquehanna International Group, LLP | 62,965 | $149.0K | 0.00% |
| Qube Research & Technologies Ltd | 33,908 | $80.0K | 0.00% |
| Boothbay Fund Management, LLC | 15,033 | $35.0K | 0.00% |
| Man Group plc | – | $35.0K | 0.00% |
| LMR Partners LLP | 13,229 | $31.0K | 0.00% |
| Prudential Financial Inc | 11,250 | $27.0K | 0.00% |
| Engineers Gate Manager LP | 10,798 | $25.0K | 0.00% |
Sold out (34)
Institutions that held Passage BIO, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (4)
Institutions that held Passage BIO, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| IndexIQ Advisors LLC | 129,561 | $402.0K |
| Parametric Portfolio Associates LLC | 28,753 | $89.0K |
| Virginia Retirement Systems Et Al | 16,200 | $50.0K |
| Amalgamated Financial Corp. | 4,485 | $14.0K |